1. Aventis Pharma Deutschland, Gmbh (13 from 330 patents)

2. Hoechst Aktiengesellschaft (8 from 6,662 patents)

3. Other (6 from 832,912 patents)

4. Genentech, Inc. (3 from 3,224 patents)

5. Aventis Pharma S.a. (2 from 377 patents)

6. Sanofi-A Ventis Deutschland Gmbh (1 from 1,832 patents)

7. Sanofi-Aventis (1 from 389 patents)

8. Hoechst Marion Roussel Deutschland Gmbh (1 from 18 patents)

9. Hoechst Aktiengesellschaft Ag (1 from 5 patents)

10. Sanofi (1,456 patents)

1. 8211885 - Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals

2. 7348333 - Cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists

3. 7342029 - Substituted indoles

4. 6962937 - Imidazolidine derivatives, their preparation and their use

5. 6867208 - Vitronectin receptor antagonists, their preparation and their use

6. 6838439 - Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists

7. 6794517 - Bis(trifluoromethyl)hydantoins as intermediates for pharmaceutically active ingredients

8. 6759424 - Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them

9. 6680333 - Imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them

10. 6667334 - Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same

11. 6620820 - Inhibitors of bone reabsorption and antagonists of vitronectin receptors

12. 6521654 - Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them

13. 6514952 - Hydantoin derivatives as inhibitors of leucocyte adhesion and as VLA-4 antagonists

14. 6482821 - Vitronectin receptor antagonists, their preparation and their use

15. 6423712 - 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them